NuPathe (NASDAQ: PATH) (Acquired)

Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkin....

Get a Demo and See the Full Profile

Get a demo today to see profiles of NuPathe (NASDAQ: PATH) (Acquired) plus 5979 other startups.

Learn More About NuPathe (NASDAQ: PATH) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More